國際醫學(000516.SZ):參股公司漢氏聯合4月21日起終止在新三板掛牌
格隆匯4月17日丨國際醫學(000516.SZ)公佈,公司的參股公司北京漢氏聯合生物技術股份有限公司(“漢氏聯合”)於2020年4月3日向全國中小企業股份轉讓系統有限責任公司報送了終止掛牌的申請材料,並於當天收到全國中小企業股份轉讓系統有限責任公司下發的《受理通知書》(編號:ZZGP2020040008)。
近日,公司收到漢氏聯合通知,根據全國中小企業股份轉讓系統有限責任公司出具的《關於同意北京漢氏聯合生物技術股份有限公司股票終止在全國中小企業股份轉讓系統掛牌的函》(編號:股轉系統函[2020]933號),漢氏聯合公司股票(證券代碼:834909,證券簡稱:漢氏聯合)自2020年4月21日起終止在全國中小企業股份轉讓系統掛牌。
截至目前,公司持有漢氏聯合30.79%的股份。漢氏聯合在全國中小企業股份轉讓系統終止掛牌不會對公司的經營活動產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.